RAISIO AND UNILEVER AGREE ON CROSS-LICENSING
Raisio plc Stock Exchange Release 21 December 2007
RAISIO AND UNILEVER AGREE ON CROSS-LICENSING
Raisio plc and Unilever have agreed on partial cross-licensing and thereby
granting non-exclusive rights to the global plant sterol and stanol patents
defined between the companies. This agreement is a conclusion to the opposition
proceedings between the companies.
Matti Rihko, CEO of Raisio, considers this an important agreement. “This
agreement strengthens significantly the IPR-portfolio that is the base of the
Benecol business. The cross-licensing agreement with Unilever is an indication
of Raisio's high-quality, internationally acknowledged research and development
of the Benecol ingredient. This agreement guarantees that both parties can
concentrate on developing their business and applications instead of defending
their patent portfolios in opposition proceedings.”
RAISIO PLC
Heidi Hirvonen
Communications Manager
tel. +358 2 443 2242 or +358 50 567 3060
Further information:
Matti Rihko, CEO, tel. +358 400 830 727
Distribution
OMX Nordic Exchange, Helsinki
Key media
www.raisio.com